Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliglustat in Chinese adults with type 1 Gaucher disease
ChiCTR2500104033Phase 4Completed
- Sponsor
- Chinese PLA General Hospita
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of eliglustat in Gaucher disease type 1 (GD1), sponsored by Chinese PLA General Hospita. Primary endpoints: Spleen volume, Hemoglobin level and 1 more. Started Jun 2025; status: completed.
02
Drugs
eliglustat
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on ChiCTR2500104033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104033.